Literature DB >> 22751196

Autophagy in intra-hepatic cholangiocarcinoma.

Jing Li Huang1, Aram F Hezel.   

Abstract

Intra-hepatic cholangiocarcinoma (IHCC) is a primary cancer of the liver that shares histological features with the hepatic bile ducts from which it is thought to arise. The incidence of this disease is increasing, possibly related to increased inflammatory liver diseases such as viral hepatitis and steatohepatitis (commonly called "fatty liver"), induced by obesity, diabetes, and other metabolic derangements. Its prognosis is generally poor with early metastasis and presently there are limited effective treatments. A basic understanding of the disease has long been hampered by limited tumor cell lines and good model systems. Similarly, such limitations have obstructed new therapeutic inroads.

Entities:  

Keywords:  KRAS; biliary tract cancer; cholangiocarcinoma; mouse model

Mesh:

Substances:

Year:  2012        PMID: 22751196      PMCID: PMC3429554          DOI: 10.4161/auto.20647

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  6 in total

1.  HDAC6-dependent ciliophagy is involved in ciliary loss and cholangiocarcinoma growth in human cells and murine models.

Authors:  Estanislao Peixoto; Sujeong Jin; Kristen Thelen; Aalekhya Biswas; Seth Richard; Manuela Morleo; Adrian Mansini; Stephanie Holtorf; Fabrizia Carbone; Nunzia Pastore; Andrea Ballabio; Brunella Franco; Sergio A Gradilone
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-04-27       Impact factor: 4.052

Review 2.  Autophagy in liver diseases.

Authors:  Elias Kouroumalis; Argryro Voumvouraki; Aikaterini Augoustaki; Dimitrios N Samonakis
Journal:  World J Hepatol       Date:  2021-01-27

3.  Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse.

Authors:  Suyanee Thongchot; Chiara Vidoni; Alessandra Ferraresi; Watcharin Loilome; Narong Khuntikeo; Sakkarn Sangkhamanon; Attapol Titapun; Ciro Isidoro; Nisana Namwat
Journal:  Cancers (Basel)       Date:  2021-04-28       Impact factor: 6.639

4.  Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection.

Authors:  Daw-Shyong Perng; Chao-Ming Hung; Hung-Yu Lin; Paul Morgan; Yao-Chun Hsu; Tsung-Chin Wu; Pei-Min Hsieh; Jen-Hao Yeh; Pojen Hsiao; Chih-Yuan Lee; Yu-Chan Li; Ya-Chin Wang; Yaw-Sen Chen; Chih-Wen Lin
Journal:  BMC Cancer       Date:  2021-07-17       Impact factor: 4.430

5.  Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells.

Authors:  Xiwei Ding; Roongruedee Chaiteerakij; Catherine D Moser; Hassan Shaleh; Jeffrey Boakye; Gang Chen; Albert Ndzengue; Ying Li; Yanling Zhou; Shengbing Huang; Frank A Sinicrope; Xiaoping Zou; Melanie B Thomas; Charles D Smith; Lewis R Roberts
Journal:  Oncotarget       Date:  2016-04-12

Review 6.  Therapeutic Potential of Autophagy Modulation in Cholangiocarcinoma.

Authors:  Hector Perez-Montoyo
Journal:  Cells       Date:  2020-03-04       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.